Psychiatric aspects of impulsivity

American Journal of Psychiatry

Volumn 158, Issue 11, 2001, Pages 1783-1793

  Moeller, F G ^a   Barratt, E S ^a   Dougherty, D M ^a   Schmitz, J M ^a   Swann, A C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LITHIUM; METHYLPHENIDATE; PHENYTOIN; PINDOLOL; PROPRANOLOL; RISPERIDONE; VALPROATE SEMISODIUM;

ATTENTION DEFICIT DISORDER; COMORBIDITY; HUMAN; IMPULSIVENESS; MANIC DEPRESSIVE PSYCHOSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE;

ANTIPSYCHOTIC AGENTS; ANTISOCIAL PERSONALITY DISORDER; BIPOLAR DISORDER; BORDERLINE PERSONALITY DISORDER; COMORBIDITY; EVOKED POTENTIALS; HUMANS; IMPULSE CONTROL DISORDERS; PERSONALITY INVENTORY; PSYCHOTHERAPY; SUBSTANCE-RELATED DISORDERS;

EID: 0035157965     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.11.1783     Document Type: Review

References (118)

1. Impulsivity and information processing
2. The place of impulsiveness in a dimensional system of personality description
3. Factor structure of the Barratt Impulsiveness Scale
4. Impulsivity scores in patients with obsessive-compulsive disorder
5. Impulsivity and serotonergic function in compulsive personality disorder
6. Alcohol effects on movement-related potentials: A measure of impulsivity?
7. Studies of violent and nonviolent male parolees, II: Laboratory and psychometric measurements of impulsivity
8. Laboratory measures of aggression and impulsivity in women with borderline personality disorder
9. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression
10. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior
11. The effects of phenytoin on impulsive and premeditated aggression: A controlled study
12. The dominance of behavioural activation over behavioural inhibition in conduct disordered boys with or without attention deficit hyperactivity disorder
13. Specious reward: A behavioral theory of impulsiveness and impulse control
14. Alcohol increases commission error rates for a continuous performance test
15. Subtype analysis of commission errors on the Continuous Performance Test
16. A family theory of impulsivity
17. Age norms for impulsiveness, venturesomeness and empathy in adults
18. The pharmacology of impulsive behaviour in rats, VII: The effects of serotonergic agonists and antagonists on responding under a discrimination task using unreliable visual stimuli
19. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task
20. Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence
21. Impulsiveness, aggression, reading, and the P300 of the event-related potential
22. Auditory P300 event related potential in minor ischemic stroke
23. Event-related potentials and thought disorder in schizophrenia
24. A model of the limbic system and basal ganglia: Applications to anxiety and schizophrenia
25. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli
26. Executive functioning, attention and frontal lesions in patients with chronic CHI
27. Signs and symptoms of mania in pure and mixed episodes
28. Structure of mania: Subgroups with distinct clinical characteristics and course of illness in randomized clinical trial participants
29. Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive aggressive behavior
30. Impaired social response reversal: A case of acquired sociopathy
31. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli
32. Deciding advantageously before knowing the advantageous strategy
33. Impulsivity: Core aspect of borderline personality disorder
34. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: A comparative study
35. Risk factors for suicidal behavior in borderline personality disorder
36. Toward a clinical model of suicidal behavior in psychiatric patients
37. The relationship between substance use disorders, impulse control disorders, and pathological aggression
38. Impulsivity and history of drug dependence
39. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse
40. Impulse-control disorders in alcoholics are related to sensation seeking and not to impulsivity
41. Multi-impulsive personality disorder and multiple substance abuse: Evidence from members of self-help groups
42. Impulsivity and DSM-III-R personality disorders
43. Impulsivity, coping styles, and triggers for craving in substance abusers with borderline personality disorder
44. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls
45. Measures of impulsivity in cigarette smokers and non-smokers
46. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control patients: Drug and monetary rewards
47. Hyperbolic temporal discounting in social drinkers and problem drinkers
48. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence
49. Treated delinquent boys' substance use: Onset, pattern, relationship to conduct and mood disorders
50. Pathways from ADHD to early drug use
51. Interactive effects of attention deficit hyperactivity disorder and conduct disorder on early adolescent substance use
52. Impulsivity: A relevant dimension in depression regarding suicide attempts?
53. Central serotonin and impulsive aggression
54. Measurement of inter-episode impulsivity in bipolar disorder
55. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample
56. Lithium carbonate treatment of mania: Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome
57. Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins
58. Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity
59. Sustained attention in hyperactive children
60. Effects of methylphenidate and nonverbal learning in children with attention-deficit hyperactivity disorder
61. Differential assessment of attention and impulsivity in children
62. Selective and sustained attention in hyperactive, learning-disabled and normal boys
63. The Biochemical Basis of Neuropharmacology
64. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
65. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder
66. 18F]DOPA accumulation in children with attention deficit hyperactivity disorder
67. Technique in regard to some specific ego defects in the treatment of borderline patients
68. A critical review of psychotherapeutic treatments of borderline personality
69. A theory of anxiety: The role of the limbic system
70. Interpersonal and emotional problem-solving among narcotic drug abusers
71. Problem-solving thinking of youthful incarcerated heroin addicts
72. Adolescent problem-solving thinking
73. Training in interpersonal problem solving (TIPS)
74. Effects of interpersonal problem-solving training with chronic aftercare patients on problem-solving component skills and effectiveness of solutions
75. Interpersonal problem solving in young children: A cognitive approach to prevention
76. Increasing the interpersonal problem-solving skills of an alcoholic population
77. Dialectical behavioral therapy in groups: Treating borderline personality disorders and suicidal behavior
78. Cognitive-behavioral treatment of chronically parasuicidal borderline patients
79. Cognitive and behavioral treatment of impulsivity in children: A meta-analytic review of the outcome literature
80. Contingent methadone delivery: Effects on illicit-opiate use
81. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up
82. A behavioral-educational alternative to drug control of hyperactive children
83. Behavioral intervention with hyperactive children
84. Behavioral treatment
85. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit hyperactivity disorder in the classroom
86. An open, noncomparative study of amoxapine in borderline disorders
87. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder
88. The effect of lithium on impulsive aggressive behavior in man
89. Lithium in hospitalized aggressive chilren with conduct disorder: A double-blind and placebo-controlled study
90. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder
91. Lithium treatment of conduct disorders in adolescents
92. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects
93. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder
94. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia
95. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia
96. Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design
97. Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study
98. Psychopharmacologic treatment of pathologic aggression
99. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial: Risperidone Study Group
100. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
101. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders
102. A double-blind pilot study of risperidone in the treatment of conduct disorder
103. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: A double-blind study
104. Propranolol treatment of assaultive patients with organic brain disease: A double-blind crossover, placebo-controlled study
105. Methylphenidate in hyperkinetic children: Differences in dose effects on impulsive behavior
106. Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions
107. Effects of methylphenidate on impulsive responding in children with attention-deficit hyperactivity disorder
108. Methylphenidate response in aggressive and nonaggressive ADHD children: Distinctions on laboratory measures of symptoms
109. Hyperactivity in preschoolers and the effect of methylphenidate
110. Impulsivity: Integrating cognitive, behavioral, biological, and environmental data
111. Defining, measuring, and predicting impulsive aggression: A heuristic model